Fatal infection of Pneumocystis jiroveci pneumonia in a pemphigus patient treated with rituximab
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.14144
Abstract: Rituximab is an effective treatment for pemphigus and can be considered as a first-line treatment for severe cases.1-4 Rituximab increases the risk of infection with Pneumocystis jiroveci pneumonia (PJP), an opportunistic pathogen, especially in hematopoietic… read more here.
Keywords: infection; jiroveci pneumonia; infection pneumocystis; treated rituximab ... See more keywords